Product Code: GDME1390EPD
GlobalData's Medical Devices sector report, "Topical Absorbable Hemostats Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Topical Absorbable Hemostats pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Topical absorbable hemostats are agents used to promote and accelerate hemostasis to control bleeding in cases where application of pressure, ligature and other conventional methods is ineffective.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Topical Absorbable Hemostats under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Topical Absorbable Hemostats and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Topical Absorbable Hemostats under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Introduction
- 2.1 Topical Absorbable Hemostats Overview
3 Products under Development
- 3.1 Topical Absorbable Hemostats - Pipeline Products by Stage of Development
- 3.2 Topical Absorbable Hemostats - Pipeline Products by Segment
- 3.3 Topical Absorbable Hemostats - Pipeline Products by Territory
- 3.4 Topical Absorbable Hemostats - Pipeline Products by Regulatory Path
- 3.5 Topical Absorbable Hemostats - Pipeline Products by Estimated Approval Date
- 3.6 Topical Absorbable Hemostats - Ongoing Clinical Trials
4 Topical Absorbable Hemostats - Pipeline Products under Development by Companies
- 4.1 Topical Absorbable Hemostats Companies - Pipeline Products by Stage of Development
- 4.2 Topical Absorbable Hemostats - Pipeline Products by Stage of Development
5 Topical Absorbable Hemostats Companies and Product Overview
- 5.1 3-D Matrix Ltd Company Overview
- 5.2 Acro Biomedical Co Ltd Company Overview
- 5.3 Advanced Biotech Products Pvt Ltd Company Overview
- 5.4 Angiotech Pharmaceuticals Inc Company Overview
- 5.5 Anika Therapeutics Inc Company Overview
- 5.6 APRUS Bio-Medical Innovations Pvt Ltd Company Overview
- 5.7 Arch Therapeutics Inc Company Overview
- 5.8 Baxter Healthcare Corp Company Overview
- 5.9 Beth Israel Deaconess Medical Center Company Overview
- 5.10 Biomedica Management Corp Company Overview
- 5.11 Biom'Up SAS Company Overview
- 5.12 Cellphire Inc Company Overview
- 5.13 Ceramicos Para Aplicacoes Medicas SA Company Overview
- 5.14 Columbia University Company Overview
- 5.15 Covalent Medical, Inc. (Inactive) Company Overview
- 5.16 Covalon Technologies Ltd Company Overview
- 5.17 CR Bard Inc Company Overview
- 5.18 Cresilon Inc Company Overview
- 5.19 Endomedix Incorporated Company Overview
- 5.20 Entegrion Inc Company Overview
- 5.21 Ethicon US LLC Company Overview
- 5.22 ETX Pharma Inc Company Overview
- 5.23 Gamma Diagnostics Inc Company Overview
- 5.24 GATT Technologies BV Company Overview
- 5.25 Haemostatix Ltd Company Overview
- 5.26 Hemostasis LLC Company Overview
- 5.27 HLL Lifecare Ltd Company Overview
- 5.28 Ichor Sciences LLC Company Overview
- 5.29 Keratin Biosciences Inc Company Overview
- 5.30 Leader Biomedical Europe BV Company Overview
- 5.31 Medcura Inc Company Overview
- 5.32 Protege Biomedical LLC Company Overview
- 5.33 Resorba GmbH Company Overview
- 5.34 Rice University Company Overview
- 5.35 Sanofi Biosurgery Inc Company Overview
- 5.36 Sea Run Holdings Inc Company Overview
- 5.37 St Teresa Medical Inc Company Overview
- 5.38 STB Lifesaving Technologies Company Overview
- 5.39 Tectum Company Overview
- 5.40 The Medicines Co Company Overview
- 5.41 Therus Corporation Company Overview
- 5.42 Thrombotargets Corp Company Overview
- 5.43 United Health Products, Inc. Company Overview
- 5.44 University of Grenoble Alpes Company Overview
- 5.45 Virginia Commonwealth University Company Overview
- 5.46 Xcede Technologies Inc Company Overview
- 5.47 Z-Medica LLC Company Overview
6 Topical Absorbable Hemostats- Recent Developments
- 6.1 Jun 10, 2022: Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
- 6.2 Jun 08, 2022: Baxter to Host Second-Quarter 2022 Financial Results Conference Call for Investors
- 6.3 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results
- 6.4 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase
- 6.5 May 25, 2022: Baxter Highlights Business Strategies and Innovation at 2022 Investor Conference
- 6.6 May 16, 2022: Analysts Anticipate Artivion to Announce $0.09 Earnings Per Share
- 6.7 May 13, 2022: Cadila Pharma appoints Jawed Zia as CEO
- 6.8 May 12, 2022: Johnson & Johnson to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference
- 6.9 May 11, 2022: Johnson & Johnson Appoints Thibaut Mongon as CEO Designate of Planned New Consumer Health Company
- 6.10 May 10, 2022: Johnson & Johnson MedTech Adds New CFO to the Mix
- 6.11 May 10, 2022: Baxter to Host 2022 Investor Conference
- 6.12 May 09, 2022: Anika to Participate in the UBS Global Healthcare Conference 2022
- 6.13 May 05, 2022: Anika Reports First Quarter Fiscal 2022 Financial Results
- 6.14 May 03, 2022: Sanofi: Annual General Meeting of May 3, 2022
- 6.15 May 02, 2022: Johnson & Johnson to Participate in the Bernstein 38th Annual Strategic Decisions Conference
- 6.16 Apr 27, 2022: Merit Medical Reports Results for Quarter Ended March 31, 2022
- 6.17 Apr 21, 2022: Artivion Announces Release Date and Teleconference Call Details for First Quarter 2022 Financial Results
- 6.18 Apr 21, 2022: Merit Medical Announces Chief Operating Officer Transition
- 6.19 Apr 20, 2022: Johnson & Johnson to Participate in the UBS Global Healthcare Conference
- 6.20 Apr 19, 2022: Johnson & Johnson Reports Q1 2022 Results
- 6.21 Apr 07, 2022: Anika to Issue First Quarter 2022 Financial Results on Thursday, May 5, 2022
- 6.22 Apr 07, 2022: Johnson & Johnson to Participate in the BofA Securities 2022 Healthcare Conference
- 6.23 Apr 04, 2022: Anika to Participate in the 21st Annual Needham Virtual Healthcare Conference
- 6.24 Mar 15, 2022: Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
- 6.25 Mar 10, 2022: Anika to Participate in the Canaccord Genuity Musculoskeletal Conference
- 6.26 Mar 09, 2022: Artivion to Host Investor & Analyst Day on March 23, 2022
- 6.27 Mar 08, 2022: Anika Reports Fourth Quarter and Year-End 2021 Financial Results
- 6.28 Feb 22, 2022: Sanara MedTech Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2021
- 6.29 Feb 15, 2022: Johnson & Johnson Names Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, to its Board of Directors
- 6.30 Feb 10, 2022: Baxter to Present at Citi's 2022 Virtual Healthcare Conference
- 6.31 Feb 09, 2022: Johnson & Johnson to Participate in the Raymond James 43rd Annual Institutional Investors Conference
- 6.32 Feb 08, 2022: Anika to Issue Fourth Quarter and Year-End 2021 Financial Results on Tuesday, March 8, 2022
- 6.33 Feb 07, 2022: Johnson & Johnson to Participate in the Cowen 42nd Annual Health Care Virtual Conference
- 6.34 Jan 27, 2022: Johnson & Johnson to Participate in Citi's 2022 Virtual Healthcare Conference
- 6.35 Jan 25, 2022: Johnson & Johnson Reports Q4 and Full-Year 2021 Results
- 6.36 Jan 06, 2022: Baxter to Host Fourth-Quarter 2021 Financial Results Conference Call for Investors
- 6.37 Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
- 6.38 Jan 04, 2022: Arch Therapeutics Announces Appointment of Guy Fish to the Board
- 6.39 Dec 22, 2021: Sanara MedTech Announces the Retirement of J. Michael Carmena and Appointment of Eric Tanzberger to its Board of Directors
- 6.40 Dec 22, 2021: United Health Products provides regulatory status update
- 6.41 Dec 15, 2021: Sanara MedTech Announces the Appointment of Roszell Mack III to its Board of Directors
- 6.42 Dec 13, 2021: Covalon Announces Strong Year End and Fourth Quarter Results for Fiscal 2021
- 6.43 Dec 10, 2021: Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
- 6.44 Dec 08, 2021: Johnson & Johnson to Participate in the 40th Annual J.P. Morgan Healthcare Conference
- 6.45 Dec 08, 2021: Dr Jens von Lackum appointed to the Management Board of B. Braun SE
- 6.46 Nov 18, 2021: Anika to Participate in Upcoming Investor Conferences
- 6.47 Nov 08, 2021: IntelliCentrics and EUCARE Announce Strategic Partnership Supporting Delivery of Taiwan's High-Quality, Integrated Medical Services to the World
- 6.48 Nov 04, 2021: Anika Reports Third Quarter 2021 Financial Results
- 6.49 Nov 02, 2021: Baxter to Present at Evercore ISI 4th Annual HealthCONx Conference
- 6.50 Nov 01, 2021: Anika Appoints Sheryl Conley to Board of Directors
- 6.51 Oct 28, 2021: Sanofi announces strong Q3 performance drives guidance upgrade to around 14% business EPS growth at CER
- 6.52 Oct 28, 2021: Merit Medical Reports Results For Quarter Ended September 30, 2021
- 6.53 Oct 18, 2021: Anika to Issue Third Quarter 2021 Financial Results on Thursday, November 4, 2021
- 6.54 Oct 13, 2021: Baxter to Present at Credit Suisse 30th Annual Virtual Healthcare Conference
- 6.55 Oct 12, 2021: Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire, Effective December 31, 2021
- 6.56 Oct 12, 2021: Johnson & Johnson Announces Jessica Moore as Vice President of Investor Relations
- 6.57 Oct 11, 2021: Johnson & Johnson to Participate in the Credit Suisse 30th Annual Healthcare Conference
- 6.58 Oct 05, 2021: Merit Medical Systems to Announce Third Quarter Results on October 28, 2021
- 6.59 Sep 27, 2021: Baxter to Host Third-Quarter 2021 Financial Results Conference Call for Investors
- 6.60 Sep 22, 2021: Anthony Semedo Joins CryoLife Board of Directors
- 6.61 Sep 16, 2021: Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
- 6.62 Sep 09, 2021: Merit Medical Systems to Announce First Quarter Results on April 29, 2021
- 6.63 Sep 07, 2021: Anika to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
- 6.64 Aug 30, 2021: Covalon Announces Fiscal 2021 Q3 Results
- 6.65 Aug 19, 2021: Alex Gorsky to Serve as Executive Chairman and Transition Role of Chief Executive Officer of Johnson & Johnson to Joaquin Duato, Effective January 3, 2022
- 6.66 Aug 12, 2021: Johnson & Johnson to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
- 6.67 Aug 09, 2021: Johnson & Johnson to Participate in Barclays Global Consumer Staples Virtual Conference
- 6.68 Jul 29, 2021: Baxter Reports Second-Quarter 2021 Results
- 6.69 Jul 29, 2021: Sanofi announces half-year financial report for period ending June 30, 2021
- 6.70 Jul 29, 2021: Baxter to Present at UBS Genomics 2.0 and MedTech Innovations Summit
- 6.71 Jul 29, 2021: CryoLife Reports Second Quarter 2021 Financial Results
- 6.72 Jul 27, 2021: Johnson & Johnson to Participate in the Virtual Wells Fargo Healthcare Conference
- 6.73 Jul 27, 2021: Stryker reports second quarter 2021 operating results
- 6.74 Jul 21, 2021: Johnson & Johnson Reports 2021 Second-Quarter Results
- 6.75 Jul 19, 2021: Anika to Issue Second Quarter 2021 Financial Results on Thursday, August 5, 2021
- 6.76 Jul 15, 2021: CryoLife Announces Release Date and Teleconference Call Details for Second Quarter 2021 Financial Results
- 6.77 Jul 09, 2021: Merit Medical Systems to Announce Second Quarter Results on July 29, 2021
- 6.78 Jul 07, 2021: Advanced Medical Solutions Group: Half year trading update
- 6.79 Jun 30, 2021: B. Braun Announces Jennifer Prioleau as New Chief Legal Officer and Chief Compliance Officer
7 Appendix
- 7.1 Methodology
- 7.2 About GlobalData
- 7.3 Contact Us
- 7.4 Disclaimer